Bispecific antibodies for relapsed/refractory MM show rapid uptake in community settings, with older patients than those in clinical trials. Real-world data indicate high discontinuation rates for ...

Bispecific antibodies show strong initial uptake in community settings for multiple myeloma treatment, particularly among Black patients compared with clinical trials. Initial uptake of bispecific ...

New 'hypervirulent' strains of the bacterium Klebsiella pneumoniae have emerged in healthy people in community settings, prompting a research group to investigate how the human immune system defends ...

Integrating trials into community health systems presents distinct challenges, but if done successfully, would open up research for a more diverse and inclusive patient population, address industry ...

Little is known about the specific needs during training for hematology/oncology providers practicing in community-based settings. We conducted a national survey of ...